NeoGenomics 新闻与活动
在场
NeoGenomics 是一家在股票代码 NEO (US) 下上市的公司。
高管
查看带有其 30 名主要高管的组织结构图
NeoGenomics 搜索最多的简介
- Tony Zook, Chief Executive Officer and Director
- Lynn Tetrault, Non-Executive Chairman of the Board
- Alison Hannah, Director and Chair of the Compliance Committee
高管在NeoGenomics变化
- Warren Stone 曾任 Chief Commercial Officer, 将于 20254月1 升职为 President and Chief Operating Officer (新闻发布的2025三月19号).
- Chris Smith, Chief Executive Officer and Director, 将于 20254月1 退休 (新闻发布的2025一月12号).
- Tony Zook 曾任 Independent Director, 将于 20254月1 升职为 Chief Executive Officer (新闻发布的2025一月12号).
创建提醒
跟踪 NeoGenomics 的高管变动
健康
NeoGenomics 拥有 2,050 家竞争者，其中包括 UnitedHealth Group (美国(美洲))、Siemens Healthineers (德国) 和 Optum (美国(美洲))。
Popular M&A news in 健康
- Accolade and Accolade have announced they will merge (公布2025四月9号)..
- Solace Health 刚刚宣布为 60 筹款数百万美元。 (公布2025四月4号).
- Navina 刚刚宣布为 55 筹款数百万美元。 (公布2025三月30号).
健康 行业的其他推荐联系人
消息
NeoGenomics 的最新新闻稿
- Adaptive Biotechnologies and NeoGenomics Partner to Expand Access to Personalized Disease Monitoring for Blood Cancer Patients
- NeoGenomics Announces Chief Executive Officer Succession
- NeoGenomics Provides 2025 Financial Guidance and Updates Long-Range Financial Plan
- NeoGenomics to Participate in the 43rd Annual J.P. Morgan Healthcare Conference
- NeoGenomics’ Newly Published Study Underscores Potential of ctDNA as a Predictive Tool for Monitoring Patients with High-Risk Melanoma
- NeoGenomics to Present Key Research on Hematologic Malignancies at the 2024 American Society of Hematology Annual Meeting
- NeoGenomics to Present New Data at AMP 2024, Highlighting the Impact of ctDNA and NGS for Advancing Cancer Diagnostics and Personalized Treatment
- Press Release | NeoGenomics Laboratories
- Felicia Williams Joins NeoGenomics Board of Directors
- NeoGenomics to Participate in the Piper Sandler 36th Annual Healthcare Conference
- View more press releases Close
